RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      전정맥마취 유도 시 기관내 삽관에 적당한 Remifentanil과 Propofol의 효과처 농도 조합 = Adequate Combination of Target Effect-Site Concentration of Propofol and Remifentanil for Tracheal Intubation

      한글로보기

      https://www.riss.kr/link?id=A104327788

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      We wanted to determine an adequate combination of target effect-site concentrations of remifentanil and propofol during anesthetic induction with target controlled infusion (TCI).We also determined whether increasing remifentanil concentrations might reduce propofol consumption at loss of consciousness (LOC).
      Methods: Sixty ASA 1 or 2 patients were randomly allocated according to the target effect-site concentration of remifentanil and propofol (R7P3: remifentanil 7 ng/ml + propofol 3μg/ml, R5P4: remifentanil 5 ng/ml + propofol 4μg/ml, R3P5: remifentanil 3 ng/ml + propofol 5μg/ml). After the target effect-site concentration of remifentanil had been reached, the TCI of propofol was started. The effect-site concentration of propofol at LOC was recorded. When the target effect-site concentration of propofol was reached, 0.6 mg/kg of rocuronium was administered. Tracheal intubation was performed after 2 minutes. The noninvasive blood pressure, heart rate (HR), bispectral index (BIS), and infused dose of remifentanil and propofol were recorded.
      Results: R3P5 groupd showed a significant increase in mean blood pressure after intubation (104 ± 31.9 mmHg, P < 0.05) compared to R7P3 and R5P4. BIS at the time when propofol reached its target effect-site concentration was significantly higher in the R7P3 group (71.6 ± 9.9, P < 0.05 compared to R5P4 and R3P5). There was a significant relationship between the effect-site concentration of remifentanil and propofol at LOC (Y = 2.032 − 0.351X, R2 = 0.551, P < 0.0001).
      Conclusions: The R5P4 target effect-site concentrations are adequate dosing combinations during TCI induction based on hemodynamic responses and BIS values.
      번역하기

      We wanted to determine an adequate combination of target effect-site concentrations of remifentanil and propofol during anesthetic induction with target controlled infusion (TCI).We also determined whether increasing remifentanil concentrations might ...

      We wanted to determine an adequate combination of target effect-site concentrations of remifentanil and propofol during anesthetic induction with target controlled infusion (TCI).We also determined whether increasing remifentanil concentrations might reduce propofol consumption at loss of consciousness (LOC).
      Methods: Sixty ASA 1 or 2 patients were randomly allocated according to the target effect-site concentration of remifentanil and propofol (R7P3: remifentanil 7 ng/ml + propofol 3μg/ml, R5P4: remifentanil 5 ng/ml + propofol 4μg/ml, R3P5: remifentanil 3 ng/ml + propofol 5μg/ml). After the target effect-site concentration of remifentanil had been reached, the TCI of propofol was started. The effect-site concentration of propofol at LOC was recorded. When the target effect-site concentration of propofol was reached, 0.6 mg/kg of rocuronium was administered. Tracheal intubation was performed after 2 minutes. The noninvasive blood pressure, heart rate (HR), bispectral index (BIS), and infused dose of remifentanil and propofol were recorded.
      Results: R3P5 groupd showed a significant increase in mean blood pressure after intubation (104 ± 31.9 mmHg, P < 0.05) compared to R7P3 and R5P4. BIS at the time when propofol reached its target effect-site concentration was significantly higher in the R7P3 group (71.6 ± 9.9, P < 0.05 compared to R5P4 and R3P5). There was a significant relationship between the effect-site concentration of remifentanil and propofol at LOC (Y = 2.032 − 0.351X, R2 = 0.551, P < 0.0001).
      Conclusions: The R5P4 target effect-site concentrations are adequate dosing combinations during TCI induction based on hemodynamic responses and BIS values.

      더보기

      참고문헌 (Reference)

      1 Troy AM, "Tracheal intubating conditions using propofol and remifentanil target- controlled infusions" 57 : 1204-7, 2002

      2 Vuyk J, "The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women" 83 : 8-22, 1995

      3 Albertin A, "The effect-site concentration of remifentanil blunting cardiovascular responses to tracheal intubation and skin incision during bispectral index-guided propofol anesthesia" 101 : 125-30, 2005

      4 Guignard B, "The effect of remifentanil on the bispectral index change and hemodynamic responses after orotracheal intubation" 90 : 161-7, 2000

      5 Schraag S, "The contribution of remifentanil to middle latency auditory evoked potentials during induction of propofol anesthesia" 103 : 902-7, 2006

      6 De Castro V, "Target- controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement" 96 : 33-8, 2003

      7 Van Poucke GE, "Target controlled infusions: Targeting the effect site while limiting peak plasma concentration" 51 : 1869-75, 2004

      8 Schmidt GN, "SNAP index and bispectral index during different states of propofol/remifentanil anaesthesia" 60 : 228-34, 2005

      9 Mustola ST, "Requirements of propofol at different end-points without adjuvant and during two different steady infusions of remifentanil" 49 : 215-21, 2005

      10 Kim JT, "Remifentanil vs. lignocaine for attenuating the haemodynamic response during rapid sequence induction using propofol: double- blind randomised clinical trial" 35 : 20-3, 2007

      1 Troy AM, "Tracheal intubating conditions using propofol and remifentanil target- controlled infusions" 57 : 1204-7, 2002

      2 Vuyk J, "The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women" 83 : 8-22, 1995

      3 Albertin A, "The effect-site concentration of remifentanil blunting cardiovascular responses to tracheal intubation and skin incision during bispectral index-guided propofol anesthesia" 101 : 125-30, 2005

      4 Guignard B, "The effect of remifentanil on the bispectral index change and hemodynamic responses after orotracheal intubation" 90 : 161-7, 2000

      5 Schraag S, "The contribution of remifentanil to middle latency auditory evoked potentials during induction of propofol anesthesia" 103 : 902-7, 2006

      6 De Castro V, "Target- controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement" 96 : 33-8, 2003

      7 Van Poucke GE, "Target controlled infusions: Targeting the effect site while limiting peak plasma concentration" 51 : 1869-75, 2004

      8 Schmidt GN, "SNAP index and bispectral index during different states of propofol/remifentanil anaesthesia" 60 : 228-34, 2005

      9 Mustola ST, "Requirements of propofol at different end-points without adjuvant and during two different steady infusions of remifentanil" 49 : 215-21, 2005

      10 Kim JT, "Remifentanil vs. lignocaine for attenuating the haemodynamic response during rapid sequence induction using propofol: double- blind randomised clinical trial" 35 : 20-3, 2007

      11 이준호, "Propofol을 이용한 완전 정맥마취시 기관내 삽관으로 인한 혈역학적 변화를 억제하는 remifentanil의 효과처 농도" 대한마취과학회 52 (52): 269-274, 2007

      12 Mertens MJ, "Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remifentanil-propofol interactions" 99 : 347-59, 2003

      13 Glass PS, "Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B)" 77 : 1031-40, 1993

      14 Bouillon TW, "Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, bispectral index, and electroencephalographic approximate entropy" 100 : 1353-72, 2004

      15 Habib AS, "Effects of remifentanil and alfentanil on the cardiovascular responses to induction of anaesthesia and tracheal intubation in the elderly" 88 : 430-3, 2002

      16 Zalunardo MP, "Effects of intravenous and oral clonidine on hemodynamic and plasma-catecholamine response due to endotracheal intubation" 9 : 143-7, 1997

      17 Ugur B, "Effects of esmolol, lidocaine and fentanyl on haemodynamic responses to endotracheal intubation: a comparative study" 27 : 269-77, 2007

      18 Albertin A, "Clinical comparison of either small doses of fentanyl or remifentanil for blunting cardiovascular changes induced by tracheal intubation" 66 : 691-6, 2000

      19 Casati A, "A comparison of remifentanil and sufentanil as adjuvants during sevoflurane anesthesia with epidural analgesia for upper abdominal surgery: effects on postoperative recovery and respiratory function" 91 : 1269-73, 2000

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2013-11-27 학회명변경 한글명 : 대한마취과학회 -> 대한마취통증의학회 KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2010-07-20 학술지명변경 한글명 : 대한마취과학회지 -> Korean Journal of Anesthesiology KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2001-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.09 0.09 0.1
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.09 0.09 0.27 0.01
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼